Submitted by Anonymous (not verified) on 15 October 2025 - 9:08
Opinion/decision on a Paediatric investigation plan (PIP): Shingrix, recombinant varicella zoster virus glycoprotein E, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0328/2024
Source: